Liu B - Search Results

1

Rosell R, Vergnenegre A, Liu B, Cobo M, Massuti B, Wei J, Molina MA, Costa C, Queralt C, Taron M. Rosell R, et al. Among authors: liu b. Pulm Pharmacol Ther. 2010 Dec;23(6):508-14. doi: 10.1016/j.pupt.2010.05.003. Epub 2010 May 13. Pulm Pharmacol Ther. 2010. PMID: 20471486 Review.

2

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines.

Wei J, Liu B, Wang L, Qian X, Ding Y, Yu L. Wei J, et al. Among authors: liu b. Cancer Chemother Pharmacol. 2007 Oct;60(5):703-11. doi: 10.1007/s00280-007-0416-9. Epub 2007 Jan 26. Cancer Chemother Pharmacol. 2007. PMID: 17256130

3

Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.

Liu B, Wei J, Zou Z, Qian X, Nakamura T, Zhang W, Ding Y, Feng J, Yu L. Liu B, et al. Eur J Hum Genet. 2007 Oct;15(10):1049-53. doi: 10.1038/sj.ejhg.5201884. Epub 2007 Jun 27. Eur J Hum Genet. 2007. PMID: 17593927

4

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.

Wang T, Wei J, Qian X, Ding Y, Yu L, Liu B. Wang T, et al. Among authors: liu b. Cancer Lett. 2008 Apr 18;262(2):214-22. doi: 10.1016/j.canlet.2007.12.004. Epub 2008 Jan 11. Cancer Lett. 2008. PMID: 18248784

5

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.

Wang L, Wei J, Qian X, Yin H, Zhao Y, Yu L, Wang T, Liu B. Wang L, et al. Among authors: liu b. BMC Cancer. 2008 Apr 11;8:97. doi: 10.1186/1471-2407-8-97. BMC Cancer. 2008. PMID: 18402708 Free PMC article.

6

Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells.

Cheng Z, Wang K, Wei J, Lu X, Liu B. Cheng Z, et al. Among authors: liu b. Phytomedicine. 2010 Nov;17(13):1000-5. doi: 10.1016/j.phymed.2010.03.018. Phytomedicine. 2010. PMID: 20554191

7

CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer.

Xie L, Wei J, Qian X, Chen G, Yu L, Ding Y, Liu B. Xie L, et al. Among authors: liu b. Anticancer Res. 2010 Jun;30(6):2209-16. Anticancer Res. 2010. PMID: 20651371

8

Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.

Xie L, Chen X, Wang L, Qian X, Wang T, Wei J, Yu L, Ding Y, Zhang C, Liu B. Xie L, et al. Among authors: liu b. BMC Cancer. 2010 Oct 28;10:591. doi: 10.1186/1471-2407-10-591. BMC Cancer. 2010. PMID: 21029414 Free PMC article.

9

Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

Wei J, Xie L, Taron M, Rosell R, Liu B. Wei J, et al. Among authors: liu b. Drug News Perspect. 2010 Dec;23(10):655-61. doi: 10.1358/dnp.2010.23.10.1560143. Drug News Perspect. 2010. PMID: 21180651 Free article. Review.

10

mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.

Wei J, Costa C, Ding Y, Zou Z, Yu L, Sanchez JJ, Qian X, Chen H, Gimenez-Capitan A, Meng F, Moran T, Benlloch S, Taron M, Rosell R, Liu B. Wei J, et al. Among authors: liu b. J Natl Cancer Inst. 2011 Oct 19;103(20):1552-6. doi: 10.1093/jnci/djr326. Epub 2011 Aug 23. J Natl Cancer Inst. 2011. PMID: 21862729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,844 results

Search Page

Filters